Evidence map›Paper›PMID 39413528›Full record

Trial reportPsychoneuroendocrinology2025

Oxytocin moderates fMRI connectivity and response to implicit threat processing in cocaine use disorder.

Kyle P Blidy, Nicholas Bustos, Jennifer Spalten, Kathleen I Crum, Amber M Jarnecke, Julianne C Flanagan, Nathaniel L Baker, Megan Moran Santa-Maria, Karen J Hartwell, Kathleen T Brady and 2 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Psychoneuroendocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. [Electroacupuncture improves post-traumatic stress disorder in rats by alleviating hippocampal mitochondrial injuryNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kyle P BlidyDepartment of Neuroscience, Medical University of South Carolina, 135 Cannon Street, Charleston, SC 29425, USA.
Nicholas BustosDepartment of Neuroscience, Medical University of South Carolina, 135 Cannon Street, Charleston, SC 29425, USA.
Jennifer SpaltenDepartment of Neuroscience, Medical University of South Carolina, 135 Cannon Street, Charleston, SC 29425, USA.
Kathleen I CrumDepartment of Neuroscience, Medical University of South Carolina, 135 Cannon Street, Charleston, SC 29425, USA.
Amber M JarneckeDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA.
Julianne C FlanaganDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA; Ralph H. Johnson VA Medical Center, Charleston, SC, USA.
Nathaniel L BakerDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA.
Megan Moran Santa-MariaDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA.
Karen J HartwellDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA; Ralph H. Johnson VA Medical Center, Charleston, SC, USA.
Kathleen T BradyDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA; Ralph H. Johnson VA Medical Center, Charleston, SC, USA.
Aimee L McRae-ClarkDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA; Ralph H. Johnson VA Medical Center, Charleston, SC, USA.
Jane E JosephDepartment of Neuroscience, Medical University of South Carolina, 135 Cannon Street, Charleston, SC 29425, USA. Electronic address: josep@musc.edu.

Funding

South Carolina Clinical & Translational Research Institute (SCTR)UL1TR001450 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T., FLUME, PATRICK A · 2015 to 2024
$41.1M
The Impact of Stress and Craving on Return to Postpartum Cannabis UseU54DA016511 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI CONSTANCE GUILLE · 2018 to 2026
$15.9M
Using connectomics to characterize risk for Alzheimer's DiseaseR01AG055132 · NIA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI JOSEPH, JANE E, MINTZER, JACOBO · 2017 to 2021
$3.7M
MID-CAREER AWARD IN PATIENT-ORIENTED DRUG ABUSE RESEARCHK24DA038240 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MCRAE-CLARK, AIMEE L · 2014 to 2023
$1.9M
Neural substrates of emotion: Impact of childhood trauma and cocaine dependenceR01DA037968 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI JOSEPH, JANE E, MCRAE-CLARK, AIMEE L · 2015 to 2019
$1.6M
Identifying the neurobehavioral signature of individuals with AUD and comorbid PTSDK23AA027307 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI JARNECKE, AMBER · 2019 to 2023
$1.0M
NCATS NIH HHS UL1 TR001450NIAAA NIH HHS K23 AA027307NIA NIH HHS R01 AG055132NIDA NIH HHS K24 DA038240NIDA NIH HHS R01 DA037968NIDA NIH HHS U54 DA016511
6 · The paper itself

Abstract

Stressful social experiences play an important role in increasing vulnerability to substance use, including cocaine. Oxytocin (OXT), known for its anxiolytic properties and involvement in social functioning, has been suggested as a potential therapeutic for cocaine use disorder (CUD). However, limited research has explored OXT's influence on social stress in CUD, and no study has examined its effects on neural response to subconscious (implicit) social threat cues in this population. To address this gap, the present study administered intranasal OXT (24 IU) or placebo (PBO) to participants with CUD (CUD+, N = 76) or without CUD (CUD-, N = 61) in a randomized parallel design. Participants then completed a functional magnetic resonance imaging (fMRI) task involving briefly presented facial fear and anger (i.e., threat) cues, followed by neutral face stimuli. Whole-brain activation and amygdala functional connectivity (using psychophysiological interaction modeling) were examined in response to the facial threat cues. OXT reduced activation in the thalamus and pontine reticular formation in response to fear cues, and in the supplementary motor area for both fear and anger cues, regardless of CUD status. Additionally, under PBO, amygdala-medial prefrontal cortex connectivity to fear stimuli was negative for the CUD+ group, but under OXT, this coupling was positive, similar to the positive coupling observed for the CUD- group under both PBO and OXT administration. The finding of OXT-mediated reversal of amygdala-prefrontal coupling was specific to CUD+ and suggests that OXT alters circuitry related to threat surveillance and implicit emotion regulation in CUD. However, additional research is needed to determine whether these alterations due to OXT have clinical significance in CUD.

Indexed as

AmygdalaCocaine-Related DisordersFearMagnetic Resonance ImagingOxytocinAdministration, IntranasalAdultAngerBrainBrain MappingCuesFacial ExpressionFemaleHumansMaleYoung AdultOxytocinAmygdalaAngerBrainstemFearMedial prefrontal cortexThalamus

Identifiers

PMID39413528
PMCPMC11568897

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.